Pasithea Therapeutics (KTTA) Accumulated Depreciation (2022 - 2025)

Pasithea Therapeutics' Accumulated Depreciation history runs 4 years deep, the most recent figure standing at $47939.0 for Q2 2025.

• In Q2 2025, Accumulated Depreciation rose 45.62% year-over-year to $47939.0; the TTM figure through Jun 2025 stood at $47939.0 (up 45.62% YoY), while the FY2024 annual figure was $42353.0, up 80.32% from the prior year.
• Accumulated Depreciation came in at $47939.0 for Q2 2025 at Pasithea Therapeutics, up from $43981.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $47939.0 in Q2 2025 to a low of $3559.0 in Q4 2022.
• A 4-year average of $32510.1 and a median of $35278.0 in 2024 frame the typical range for Accumulated Depreciation.
• Across the five-year window, Accumulated Depreciation jumped 559.96% in 2023 and surged 45.62% in 2025, its largest moves.
• Pasithea Therapeutics' Accumulated Depreciation stood at $3559.0 in 2022, then surged by 559.96% to $23488.0 in 2023, then soared by 80.32% to $42353.0 in 2024, then climbed by 13.19% to $47939.0 in 2025.
• According to Business Quant data, Accumulated Depreciation over the past three periods registered $47939.0, $43981.0, and $42353.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison